chrisvoncsefalvay/vaers-outcomes huggingface dataset:
March 13 - Received first Pfizer vaccine. March 16 (approx.): Developed mild burning/tingling in feet and hands--did not associate with vaccine. Made appointment with doctor, but couldn't see her until April 8. April 3: Received second Pfizer vaccine. April 4 and 5: Chills, fever, nausea, exhaustion, burning tongue, loss of appetite. Burning/tingling in feet and hands now extreme. April 5: CDC expected symptoms subsided (chills, fever, exhaustion) April 6 to April 10:  Burning/tingling in feet/hands/tongue increased; tinnitus louder; mild nausea, loss of appetite. April 8: Saw doctor who suggested symptoms could be related to the vaccine. April 11: In addition to above, diarrhea twice - 5:00 am and 8:30 am.
Severe insomnia. Unable to fall asleep until 4:30am night of vaccination. Unable to fall asleep until 6:00am second night. Both despite feeling very tired.
Nausea after Second Shot; Headache after Second Shot; Cold after first vaccine; Chills after first vaccine; Night sweats after first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold after first vaccine), NIGHT SWEATS (Night sweats after first vaccine), NAUSEA (Nausea after Second Shot), HEADACHE (Headache after Second Shot) and CHILLS (Chills after first vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 002N20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced NIGHT SWEATS (Night sweats after first vaccine). On 07-Mar-2021, the patient experienced CHILLS (Chills after first vaccine). On 08-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold after first vaccine). On 02-Apr-2021, the patient experienced NAUSEA (Nausea after Second Shot) and HEADACHE (Headache after Second Shot). On 08-Mar-2021, NIGHT SWEATS (Night sweats after first vaccine) had resolved. On 09-Mar-2021, CHILLS (Chills after first vaccine) had resolved. On 10-Mar-2021, NASOPHARYNGITIS (Cold after first vaccine) had resolved. On 02-Apr-2021, NAUSEA (Nausea after Second Shot) and HEADACHE (Headache after Second Shot) had resolved.            No relevant concomitant medications were reported.  No treatment information was provided.
Swelling, hot, signs of inflammation at site of injection, hives and itching all over body
Reported scratchy sore throat a.m. of 03/22/16. Sneezing morning of 03/24/16. Erythema left upper arm injection site 6.5 cm x 7.5 cm. Follow up with PCP 3/24/16. Typical antihistamine and cold patch ordered.
Edema in both legs within days of vaccine.  Had ultrasound for clotting no clots.  October 2021 right thigh is numbing and edema in legs worse.  Saw doctor for blood work.
At about 7 am, Sun., 2/21/21,  as I was getting out of bed, I noticed that the skin of my left lower leg was a dusky red.  There was no pain or discomfort but my leg felt warm to the touch.  Within an hour, the redness had spread to cover all skin between my knee and ankle, however, by noon it was back to normal.  At 2:30 am, Mon., 2/22/21, I awoke with abdominal pain, diarrhea, headache, and overall feeling poorly.  There were two episodes of diarrhea in the next 8 hrs but abdominal pain disappeared.  There were several sharp bursts of headache pain but this pain also disappeared  in the next 8 hrs.
This case was reported by a pharmacist via a sales representative and described the occurrence of injection site pain in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received a dose of FLUARIX. Less than one day after vaccination with FLUARIX, the subject experienced injection site pain. The next day, the area was hard (hardiness injection site) and a blister formed (injection site blisters). It was reported that it took a week for the events (issue) to resolve. The reporter indicated that this event occurred with seven patients that received FLUARIX. Linked cases include A0950536A, A0950541A, A0950542A, A0950543A, A0950544A and A0950546A.
Asymptomatic until bedtime, 101.9 fever for 6 hours and currently 100.3, but it's fluctuating. Severe shaking chills, and throbbing bone and joint pain. My perineum also oddly feels as though I've been kicked rather hard. Sleepless night until chills subsided. Then experienced mild nausea, and pain in both palms while hand washing.  No congestion, but dry inflamed sinuses and eye pain. I developed a headache this morning, but only while standing.
Small, red lump on LT starting within 24 hrs of DTaP and has gotten larger. Child having difficulty walking on leg; cries when it is touched. Parent referred to free clinic for evaluation.
Started with fatigue that evening (extreme), grew to severe joint pain in shoulders, hips, neck was very stiff and sore, headache and arm pain. That entire night, high pain. 24 hours after injection, I broke out in a hives rash on my torso front and back, and my face. On day3, pain is lessening, and mostly remains in arm and shoulders. Rash is still present, but lighter. Is improving. I am managing symptoms at home with tylonal, benadryl, and ibuprofen.
15 minutes after receiving the second shot I felt a surge; then it was like someone was grabbing my throat, but as fast as it happened; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (15 minutes after receiving the second shot I felt a surge) and OROPHARYNGEAL DISCOMFORT (then it was like someone was grabbing my throat, but as fast as it happened) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (15 minutes after receiving the second shot I felt a surge) and OROPHARYNGEAL DISCOMFORT (then it was like someone was grabbing my throat, but as fast as it happened). At the time of the report, FEELING ABNORMAL (15 minutes after receiving the second shot I felt a surge) and OROPHARYNGEAL DISCOMFORT (then it was like someone was grabbing my throat, but as fast as it happened) outcome was unknown.            No concomitant medication was provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2021-270759 (Patient Link).   Reporter did not allow further contact
SKIN PEELING; This spontaneous report received from a patient concerned a male of unspecified age (local case ID# 002494624). The patient's weight, height, and medical history were not reported. The patient received unspecified consumer JNJ compound (form of admin, route of admin, and batch number were not reported, expiry date: UNKNOWN) dose, frequency, and therapy dates were not reported for an unspecified indication.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry date: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced skin peeling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of skin peeling was not reported. This report was non-serious.
Over Dosage of influenza vaccine was administered to participant. Recommended dose is .5 Ml and 1 ml was administered.
Fainted 3 times: once in the middle of the night when washing hands with cold water, again in the morning when washing hands with cold water, again a week later while sitting in the car.  Chills for about 1 hour the evening of the vaccination. Then mild fever that evening.
BODY ACHES; DIZZY; MIGRAINE; CHILLS; NAUSEA; FEVER; This spontaneous report received from a patient concerned a 35 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included unknown. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 12:30 to left deltoid for prophylactic vaccination. No concomitant medications were reported.  On 15-MAR-2021 20:00, the subject experienced body aches. On 15-MAR-2021 20:00, the subject experienced dizzy. On 15-MAR-2021 20:00, the subject experienced migraine. On 15-MAR-2021 20:00, the subject experienced chills. On 15-MAR-2021 20:00, the subject experienced nausea. On 15-MAR-2021 20:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea on 16-MAR-2021, and had not recovered from chills, body aches, migraine, fever, and dizzy. This report was non-serious. This parent/child case is linked to 20210336338.
Redness, swelling and pain at injection site. Approximately 1-2 inch diameter. Still having symptoms at 5pm 4/13/2016. Have not seen clinician regarding adverse affect.
02/18/2021  developed Bells Palsey on left side of head and face   Dr prescribed  steroids and viral infection meds  which I started 02/19/2021 and 02/20/2021 for 7 days    Symptoms have receded
This spontaneous report as received from a pharmacist refers to an unknown number of patients of unknown age. The patients were vaccinated with ZOSTAVAX that was stored over an unknown period of time at temperatures as high as 12F. The overall storage temperature may not have been 5F. No adverse events were reported. No treatment information was reported. Additional information has been requested.
First nigth sweats , body aches, chills, headache in the morning still not 100% went through the day until eveing headache really bad then chills and shaking uncontroably , body aches and then chest and arm and jaw pain. Hyperventalating , call 911 went to hospital had a levele of Tropion of 4 and went up to 10.5 spent 3 days in Cardovascular unit. I am now on heart medication
Headache - 2 MInutes later. Lasted 24 Hours Pain at Injection site - Started 12 hours later - Lasted 48 Hours Loud Tinnitus - 48 Hours Later - Improved but un-resolved a week later
sore arm; pain at injection site; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE PAIN (pain at injection site) and CHILLS (Chills) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 031M20A) for COVID-19 vaccination.     The patient had no known allergies.  The patient's past medical history included Vasectomy. Concomitant products included FISH OIL (FISH OIL OMEGA 3), ROSUVASTATIN, NIACIN, ASPIRIN [ACETYLSALICYLIC ACID], CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE PAIN (pain at injection site) and CHILLS (Chills). The patient was treated with IBUPROFEN for Adverse event, at a dose of 800 mg. At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE PAIN (pain at injection site) and CHILLS (Chills) outcome was unknown.            As treatment the patient also used cold compress.   This case was linked to MOD-2021-323843.
Information has been received from a nurse referring to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with the third dose in RECOMBIVAX HB (lot#, dose and route not reported) series which was improperly stored. No adverse events were reported. This is one of several reports (triplets patients, MARRS# 1502USA004588, 1502USA009115 and 1502USA009116) received from the same source. Additional information has been requested.
Pt developed a rash on 10/18 described as small, light pink, bumpy rash on back, stomach and face. Pt felt warm but temperature was not measured. Rash faded and was almost gone by 10/22. On 10/23/01 pt developed runny nose and cough but rash had subsided. Mother was advised to have pt evaluated by MD.
Pt's mom called and stated that the patient began to itch all over and now has a rash on her back and arms. Her hands are itching and she has not had any relief from using oral benadryl or any type of anti-itch cream.
Severe headache and flushing for two days. Severe arm pain on site of injection for a few hours.
Experiencing common arm pain like severe arm pain to a point where I can't touch it and I can hardly lift my arm; firstly I didn't feel anything and then it slowly has gone worse; Having severe Diarrhea and it's making 3 times everything after an hour; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Sep2021 11:00 (Lot number: FD8448) at the age of 27 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "ADHD" (unspecified if ongoing), notes: Verbatim: ADHD; "Cold sores" (unspecified if ongoing), notes: Verbatim: Cold sores. Concomitant medication(s) included: ADDERALL taken for attention deficit hyperactivity disorder; ACICLOVIR taken for oral herpes. The following information was reported: DIARRHOEA (non-serious) with onset 11Sep2021, outcome "unknown", described as "Having severe Diarrhea and it's making 3 times everything after an hour"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Experiencing common arm pain like severe arm pain to a point where I can't touch it and I can hardly lift my arm; firstly I didn't feel anything and then it slowly has gone worse". Therapeutic measures were not taken as a result of diarrhoea, pain in extremity.  Additional Information: I am calling because I think I am having symptoms from getting (first dose) Covid-19 Vaccine today around 11 am, it is now 8:37 pm. I don't know an hour after I receive Vaccine, I have been experiencing Diarrhea and it's making 3 times everything after an hour, I am having severe Diarrhea. One other side effect that I am experiencing common is arm pain, but it is like severe arm pain to a point where I can't touch it and I can hardly lift my arm. I never had such a severe arm pain with any vaccine ever. It started when I first got the vaccine, firstly I didn't feel anything and then it slowly has gone worse throughout the day. I am sure it is probably normal, but I just thought otherwise I don't have any symptoms like fever or nausea or anything.  Follow-up attempts are completed. No further information is expected.
raised swelling not painful over left arm at day 7, mildly itchy, also with small itchy papular rash sprinkled over body
Cancer; This spontaneous case was reported by a consumer and describes the occurrence of NEOPLASM MALIGNANT (Cancer) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEOPLASM MALIGNANT (Cancer) (seriousness criteria death and medically significant). The reported cause of death was Cancer. It is unknown if an autopsy was performed.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NEOPLASM MALIGNANT (Cancer) to be related.    It was unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. It was reported that the Moderna Covid-19 caused cancer in 25 patients who were the friends of reporter. The patient will not provide any additional information on these patients. It was also reported that those patients who died were killed by the Moderna Covid-19 vaccine because Moderna vaccine was poison Cancer rates for jabbed Moderna Cancer patients was up 300% The Doctors are part of the group along with Moderna. Treatment details was not reported by the reporter. This case contains information about 24th patient out of 25 patients.  Company comment:  This is a spontaneous case concerning a patient of unknown age and gender, with no reported medical history, who experienced the Fatal serious (due to medically significant) unexpected, event of Neoplasm malignant, which occurred after the mRNA-1273.222 (Original/Omicron BA.4/5) vaccine, received as part of COVID-19 vaccination schedule, dose number not provided. The patient died on an unknown date, and it is unknown whether an autopsy was performed. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273.222 (Original/Omicron BA.4/5) vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-735987 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735987:Master case, Patient 1; Reported Cause(s) of Death: Cancer
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with vaccine that has been stored in the refrigerator for 31 days) and PRODUCT STORAGE ERROR (Patient administered with vaccine that has been stored in the refrigerator for 31 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination. No Medical History information was reported. In March 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with vaccine that has been stored in the refrigerator for 31 days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient administered with vaccine that has been stored in the refrigerator for 31 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with vaccine that has been stored in the refrigerator for 31 days) and PRODUCT STORAGE ERROR (Patient administered with vaccine that has been stored in the refrigerator for 31 days) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient did not have any adverse event. The reporter stated that they had administered 4 doses to 4 patient's from the vaccine from the vial that was initially stored in the refrigerator on 15 Feb 2022. Out of which 3 doses were administered on 11 Mar 2022 and 1 dose on 21 Mar 2022. No treatment medications were reported.
Pt given oral ROTATEQ vaccine inadvertently.  Pt's family notified and verbalized child has been fine since vaccinations.  Family notified IPV vaccination still needed to be given and family states will follow up with walk in soon.
Shots 7/10/03. 8/11/03 Dx ITP platelets 13.000. 8/15/03 Varicella rash worse on left leg (not sure if site of immunization or not. Platelets up to 218,000.
This spontaneous report was received from a registered pharmacist concerning to a 71 years old female patient. On 11-DEC-2012, the patient was vaccinated subcutaneously with a dose of 0.65 ZOSTAVAX lot reported as H018088/Exp date: 04-JAN-2014. No other co-suspects were reported. No concomitant medications were reported. Pharmacist reported that the patient's injection arm was warm, and had multiple blotches. No treatment information was reported. The outcome of the event was reported as not recovered/not resolved. The relatedness for the event was unknown for ZOSTAVAX. Additional information has been requested.
Dead on Arrival at ER.  2/8/07 Received Autopsy Report which reveals COD as SIDS.  Patient was found in prone position on sofa where she slept w/adult so overlay could not be excluded.
SUFFER; WEIGHT LOSS; SIDE EFFECTS; BOTH MY LEGS FROM THE BOTTOM OF MY FEET TO MY THIGHS STARTED HURTING ME REALLY BAD; NAUSEA, START FEELING SICK TO MY STOMACH SO I STOP EATING; VOMITING; BODY ACHES; HEAT INSIDE THAT SEEMS TO MAKE MY BODY FEEL LIKE IT WAS JUST ON FIRE; BROKE OUT IN A SWEAT SOAKING MY CLOTHES; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 23-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 23-JUL-2021, the patient experienced heat inside that seems to make my body feel like it was just on fire. On 23-JUL-2021, the patient experienced broke out in a sweat soaking my clothes. On 23-JUL-2021, the patient experienced body aches. On an unspecified date, the patient experienced suffer, weight loss, side effects, both my legs from the bottom of my feet to my thighs started hurting me really bad, nausea, start feeling sick to my stomach so i stop eating, and vomiting. Laboratory data (dates unspecified) included: Blood test (not provided) Normal and COVID-19 virus test (not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heat inside that seems to make my body feel like it was just on fire, broke out in a sweat soaking my clothes, and body aches on 26-JUL-2021, had not recovered from nausea, start feeling sick to my stomach so i stop eating, both my legs from the bottom of my feet to my thighs started hurting me really bad, vomiting, and weight loss, and the outcome of suffer and side effects was not reported. This report was non-serious.
10/29 Vaccine given at work (patient is nurse on unit)- no c/o discomfort at time of injection evening following injection- increased pain at site(left deltoid)10/30increase in pain (6 on scale of 10), tingling and raised rash to left arm. 10/31 further increase in rash & pain went to PCP DX: Cellulitis given antibiotics & instructions for warm moist heat & elevation.
Pt said she got a hard bump at inflammation and her deltoid muscle has hurt since she got it.  She apparently had the same thing happen the last time she received the Moderna vaccine, but it went away sooner. I told her to call her MD if pain persists.
myocarditis/arrhythmia occurred 4 days p/vax; admitted to ICU; treated w/pressure support & antiarrhythmics
ACUTE ST ELEVATION MI, UNSPECIFIED ACUTE NON ST ELEVATION MI 3/22/2022 -- RECURRENCE OF SAME SYMPTOMS
A. itchy rash and hardness with redness developed after a week.  used over the counter hydrocortisone cream once that evening. next day the itch has subsided, the redness and hardness took 3 days to slowly fade away.
Welt, redness, and soreness at injection sight.  Very odorous diarrhea that contained large amounts of mucus; 5 occurrences.